Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Recurrence 7Burkitt Lymphoma 6Neoplasms, Plasma Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Immunoglobulin Light-chain Amyloidosis 3Neoplasms 2Neoplasm Metastasis 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Lymphoma 2Fatigue 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Oropharyngeal Neoplasms 1Neoplasm, Residual 1Nausea 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Hairy Cell 1Leukemia, Biphenotypic, Acute 1Leukemia 1Dyspnea 1

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Dexamethasone 1Cyclophosphamide 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Castration-Resistant Prostate Carcinoma × Calcium Dobesilate × Clear all
NCT05479578 2025-01-08

Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer

University of California, Davis

Phase 1 Active not recruiting
7 enrolled
Genitourinary

Castration-Resistant Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡